Literature DB >> 21686617

Relapsing encephalopathy in a patient with α-methylacyl-CoA racemase deficiency.

Sian A Thompson1, Jacqui Calvin, Sarah Hogg, Sacha Ferdinandusse, Ronald J A Wanders, Roger A Barker.   

Abstract

α-Methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.

Entities:  

Year:  2009        PMID: 21686617      PMCID: PMC3028295          DOI: 10.1136/bcr.08.2008.0814

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Refsum's disease.

Authors:  A J Wills; N J Manning; M M Reilly
Journal:  QJM       Date:  2001-08

2.  Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy.

Authors:  S Ferdinandusse; S Denis; P T Clayton; A Graham; J E Rees; J T Allen; B N McLean; A Y Brown; P Vreken; H R Waterham; R J Wanders
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 3.  Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency.

Authors:  C E Clarke; S Alger; M A Preece; M A Burdon; S Chavda; S Denis; S Ferdinandusse; R J A Wanders
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

4.  Refsum's disease: long term treatment preserves sensory nerve action potentials and motor function.

Authors:  J S Lou; R Snyder; R C Griggs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

5.  Fibroblast studies documenting a case of peroxisomal 2-methylacyl-CoA racemase deficiency: possible link between racemase deficiency and malabsorption and vitamin K deficiency.

Authors:  P P Van Veldhoven; E Meyhi; R H Squires; M Fransen; B Fournier; V Brys; M J Bennett; G P Mannaerts
Journal:  Eur J Clin Invest       Date:  2001-08       Impact factor: 4.686

Review 6.  Human metabolism of phytanic acid and pristanic acid.

Authors:  N M Verhoeven; C Jakobs
Journal:  Prog Lipid Res       Date:  2001-11       Impact factor: 16.195

7.  A new defect of peroxisomal function involving pristanic acid: a case report.

Authors:  B N McLean; J Allen; S Ferdinandusse; R J A Wanders
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

8.  In brain mitochondria the branched-chain fatty acid phytanic acid impairs energy transduction and sensitizes for permeability transition.

Authors:  Peter Schönfeld; Stefan Kahlert; Georg Reiser
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

9.  Branched chain fatty acids induce nitric oxide-dependent apoptosis in vascular smooth muscle cells.

Authors:  Susanne Idel; Peter Ellinghaus; Christian Wolfrum; Jerzy-Roch Nofer; Jolein Gloerich; Gerd Assmann; Friedrich Spener; Udo Seedorf
Journal:  J Biol Chem       Date:  2002-10-03       Impact factor: 5.157

  9 in total
  2 in total

Review 1.  Dysfunctional peroxisomal lipid metabolisms and their ocular manifestations.

Authors:  Chuck T Chen; Zhuo Shao; Zhongjie Fu
Journal:  Front Cell Dev Biol       Date:  2022-09-07

2.  Peroxisome biogenesis disorders.

Authors:  Catherine Argyriou; Maria Daniela D'Agostino; Nancy Braverman
Journal:  Transl Sci Rare Dis       Date:  2016-11-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.